Volumetric Ga-68-DOTA-TATE PET/CT for Assessment of Whole-Body Tumor Burden as a Quantitative Imaging Biomarker in Patients with Neuroendocrine Tumors
作者
Fiona Ohlendorf,Jan M. Sommerlath Sohns,Thomas Brunkhorst,Tobias L. Roß,FM Bengel,Thorsten Derlin
出处
期刊:Nuklearmedizin-nuclear Medicine [Schattauer Verlag] 日期:2019-03-01被引量:5
标识
DOI:10.1055/s-0039-1683655
摘要
Ziel/Aim: A quantitative imaging biomarker is desirable to provide a comprehensive measure of whole-body tumor burden in patients with metastatic neuroendocrine tumors, and to standardize the evaluation of treatment-related changes. Therefore, we evaluated volumetric parameters for quantification of whole-body tumor burden from somatostatin receptor (SSTR)-targeted PET/CT. Methodik/Methods: 33 patients with metastastic G1/G2 gastroenteropancreatic tumors who underwent a Ga-68-DOTA-TATE PET/CT for staging of disease before initiation of peptide receptor radionuclide therapy were included in this retrospective analysis. Volumetric parameters of tumor lesions, that is, SSTR-derived tumor volume (SSTR-TV) and total lesion SSTR (TL-SSTR), were calculated for each patient using a 3-dimensional segmentation and computerized volumetric technique with a 40% SUV max cut-off, and compared with serum chromogranin A (CgA) levels, and progression-free survival. In a subgroup of 13 patients, volumetric parameters were applied for treatment monitoring. Ergebnisse/Results: Median baseline SSTR-TV was 96 cm 3 (IQR, 41 – 321), whereas TL-SSTR was 1237 cm 3 (IQR, 572 – 6930 cm 3 ). There was a mild, but statistically significant correlation between baseline CgA levels and whole-body SSTR-TV and whole-body TL-SSTR (r s = 0.55; P = 0.001 and r s = 0.48, P = 0.004, respectively). There was a trend towards shorter PFS in patients with high SSTR-TV (≥100 cm 3 , Hazard Ratio 1.34 (95% CI 0.67 – 2.87), P = 0.40), and high TL-SSTR (≥1237 cm 3 , Hazard Ratio 1.57 (95% CI 0.81 – 3.41), P = 0.19). Using PET/CT as gold standard for treatment monitoring (PERCIST 1.0), changes in CgA provided discordant results in 8/13 cases, whereas SSTR-TV was discordant in 7/13 cases, and TL-SSTR in 6/13 cases. Schlussfolgerungen/Conclusions: SSTR-derived volumetric parameters provide a quantitative imaging biomarker for whole-body tumor burden. The value for assessment of treatment response requires further investigation.